Avicanna Enters Multi-level Strategic Partnership with Al Harrington’s, Harrington Wellness Inc., to Commercialize re+PLAY™ Branded Products in Canada and the...
- Apollomics licenses worldwide rights (ex-China, Hong Kong and Taiwan) to develop and commercialize EO1001 - - EO1001 is an...
RESEARCH TRIANGLE PARK, N.C., Feb. 09, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that data on...
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists Adam Halberstadt and John McCorvy join Jason Wallach to...
WILMETTE, Ill., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing...
Triferic AVNU Triferic® AVNU (ferric pyrophosphate citrate injection), the intravenous (IV) formulation of Triferic, is now available in the United...
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that its corporate...
Women’s Healthy Heart Initiative Heart Health Month at the MUHC Foundation MONTREAL, Feb. 09, 2021 (GLOBE NEWSWIRE) -- February is...
Company Expects to Begin Phase 2 Clinical Study in the Third Quarter of 2021BOSTON, Feb. 09, 2021 (GLOBE NEWSWIRE) --...
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (TSXV:SHG ; OTCQX:SHGFF) (“Skylight Health” or the “Company”), announced...
Initial Production of 50,000 Vials Entirely SoldMISSISSAUGA, Ontario, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB:...
Publication titled: “Targeting G542X CFTR Nonsense Alleles With ELX-02 Restores CFTR Function in Human-Derived Intestinal Organoids”WALTHAM, Mass., Feb. 09, 2021...
- Company had $81 million of cash and cash equivalents as of December 31, 2020, and expects to receive additional...
All eight patients treated with OTL-203 show stable cognitive function, motor function and growth within the normal range at multiple...
Heart disease is still the number one killer of women, yet women are under-studied, under-treated, underdiagnosed, and under-aware when it...
Phase 2 Study of oral niclosamide planned for 1H 2021 DELRAY BEACH, Fla., Feb. 09, 2021 (GLOBE NEWSWIRE) -- AzurRx...
LAVAL, Quebec, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST)...
ORION CORPORATION STOCK EXCHANGE RELEASE / NOTICE TO ANNUAL GENERAL MEETING 9 FEBRUARY 2021 at 12:15 EET Notice to the...
TEL AVIV, Israel, Feb. 09, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention...